Skip to content

Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients with Acupuncture Treatment

Clinical and Electrographic Changes in RNS System Patients with Acupuncture Treatment

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04677751
Enrollment
10
Registered
2020-12-21
Start date
2021-04-01
Completion date
2025-12-01
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

acupuncture, RNS, seizure

Brief summary

The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS System

Interventions

Participants will undergo 12 weeks of acupuncture therapy. There will be one 40 minute-1 hour. session per week.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Patient implanted with the RNS system * Patient can undergo 12 weeks of acupuncture * Patient is able remain on stable medications for 12 weeks * Patient is able to remain on stable Detection and Stimulation settings for 12 weeks * Patient or/and caregiver is able to understand and sign informed consent and HIPAA authorization * Patient or caregiver able to maintain a seizure diary for duration of study

Exclusion criteria

* Patient and /or caregiver is unable to sign informed consent to study * Patient has a bleeding disorder, pacemaker, or pregnant

Design outcomes

Primary

MeasureTime frameDescription
Percent change in number of disabling clinical seizuresBaseline,12 weeks post treatmentThis will be measured by self reporting journals
Changes in seizure severityBaseline,12 weeks post treatmentThis will be measured by self reporting journals

Secondary

MeasureTime frameDescription
Change in cognition and mood as assessed by the Quality Of Life In Epilepsy (QOLIE-10) questionnaireBaseline,12 weeks post treatmentThis is a 10 item questionnaire. Score ranges from 1-6,a higher number indicating a worse outcome.
Change in cognition and mood as assessed by the Patient Health Questionnaire (PHQ-9)Baseline,12 weeks post treatmentPHQ-9 score can range from 0 to 27,each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day).
Change in cognition and mood as assessed by the Generalized Anxiety Disorder 7-item (GAD-7) scaleBaseline,12 weeks post treatmentThis is a 7 item questionnaire. Each question is scored form 0(not at alll) to 3(nearly every day)
Average number of detections of seizures per-day (as stored by the RNS System)Baseline

Countries

United States

Contacts

Primary ContactOlga Rodziyevska, MS,PA-C
Olga.Rodziyevska@uth.tmc.edu(713) 500-5482
Backup ContactArdonia N Tousant
Ardonia.N.Tousant@uth.tmc.edu(713) 500-5482

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026